The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies
Abstract
Objective. To study cytokine expression in muscle tissues of patients with inflammatory myopathies and to compare the profiles of patients with polymyositis (PM), inclusion body myositis (IBM), and dermatomyositis (DM). Methods. We performed indirect immunohistochemistry studies of muscle tissue sections with a panel of 16 different cytokine‐specific monoclonal antibodies, directed against interleukin‐1α, (IL‐1α), IL‐1β, IL‐1 receptor antagonist (IL‐1ra), IL‐2, IL‐3, IL‐4, IL‐6, IL‐8, IL‐10, IL‐13, interferon‐γ (IFNγ), tumor necrosis factor α (TNFα), granulocyte‐macrophage colonystimulating factor (GM‐CSF), transforming growth factor β1 (TGFß1), TGFß2, and TGFß3 in 5 untreated patients each with PM, DM, and IBM and in 4 normal controls. Fresh frozen muscle tissue sections were fixed in formaldehyde before the procedure. The use of saponin as a detergent to permeabilize the cell membranes enabled identification of intracellular cytokine production. Results. The most prominent finding was the expression of IL‐1α observed in all patients but in none of the normal controls. In all patients with PM, DM, and IBM, IL‐1α was expressed in endothelial cells of capillaries, arterioles, and venules in areas surrounded by inflammatory cells, and also in areas with no or scarce inflammatory cells in both endomysium and perimysium. Furthermore, IL‐1α was also expressed in mononuclear inflammatory cells in all 15 cases. IL‐1β was observed in inflammatory cells in 10 of the 15 patients but, in contrast to IL‐1α, it was not expressed in blood vessel walls. TGFß1, TGFß2, and TGFß3 were strongly positive in all 15 patients, but only scattered cells were positive in the normal controls. The remaining cytokines were observed only in relatively few cells and only in occasional patients (although the patients were selected for the presence of large infiltrates), and in none of the controls. The patterns were similar in PM, DM, and IBM. Conclusion. Cytokine expression in muscle tissue of patients with inflammatory myopathy is dominated by IL‐1α, IL‐1β, and TGFß1–3. The predominant IL‐1α expression in the blood vessels indicates an importance of the endothelial cells in the inflammatory process in PM, IBM, and DM. A sustained, local release of T cell‐derived cytokines may not be a requirement for tissue injury in the inflammatory myopathies. There does not appear to be a qualitative difference in cytokine expression patterns in PM, IBM, and DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
Dalakas, M. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252107 · Cited by 938
Anderson, P. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520040082051 · Cited by 896
Polymyositis, Dermatomyositis, and Inclusion Body Myositis
Holton, J., Wedderburn, L. R., & Hanna, M. G. (2013) · UCL Discovery (University College London) · Cited by 764
Arahata, K., & Engel, A. G. (1984) · Annals of Neurology · doi:10.1002/ana.410160206 · Cited by 630
INCLUSION BODY MYOSITIS: OBSERVATIONS IN 40 PATIENTS
LOTZ, B. P., ENGEL, A. G., NISHINO, H., STEVENS, J. C., & LITCHY, W. J. (1989) · Brain · doi:10.1093/brain/112.3.727 · Cited by 573
High endothelial venules (HEVs): specialized endothelium for lymphocyte migration
Girard, J.-P., & Springer, T. A. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80023-9 · Cited by 552
Transforming growth factor beta: the good, the bad, and the ugly.
Wahl, S. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1587 · Cited by 486
Assessment of Cytokines by Immunofluorescence and the Paraformaldehyde‐Saponin Procedure
Sander, B., Andersson, J., & Andersson, U. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00578.x · Cited by 452
Self-citationEmslie-Smith, A. M., Arahata, K., & Engel, A. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90128-7 · Cited by 349
Engel, A. G., & Arahata, K. (1984) · Annals of Neurology · doi:10.1002/ana.410160207 · Cited by 347
Cited by
Li, Y., Foster, W., Deasy, B. M., Chan, Y., Prisk, V., Tang, Y., Cummins, J., & Huard, J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63188-4 · Cited by 451
Malm, C., Nyberg, P., Engström, M., Sjödin, B., Lenkei, R., Ekblom, B., & Lundberg, I. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00243.x · Cited by 388
Self-citationInflammation induced loss of skeletal muscle
Londhe, P., & Guttridge, D. C. (2015) · Bone · doi:10.1016/j.bone.2015.03.015 · Cited by 276
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
An overview of polymyositis and dermatomyositis
Findlay, A. R., Goyal, N. A., & Mozaffar, T. (2015) · Muscle & Nerve · doi:10.1002/mus.24566 · Cited by 259
Metadata
- Authors
- Lundberg, I., Ulfgren, A., Nyberg, P., Andersson, U., & Klareskog, L.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-05
- Volume
- 40
- Issue
- 5
- Pages
- 865-874
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2048468332
- Cited by
- 271
- References
- 20
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. https://app.cochat.ai/papers/10.1002/art.1780400514
- The paper
- Lundberg, I., Ulfgren, A., Nyberg, P., Andersson, U., & Klareskog, L. (1997). Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780400514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.